News and
Events
- Dec 21, 2022
Curesponse shows applicability with next generation immuno-oncology drugs
- May 15, 2022
Curesponse to exhibit at ASCO, 2022
- Apr 28, 2022
Curesponse to present at BIOMED Israel, 2022
- Feb 28, 2022
Curesponse publishes new clinical study in Nature Cancer
- Feb 2, 2022
Curesponse and Rafael announce collaboration
- Jan 5, 2022
Curesponse interviewed on Israel Channel 13
- Nov 5, 2021
Curesponse secures additional USD 8 Million funding
- Apr 9, 2021
Curesponse presents positive interim results at AACR 2021
- Nov 5, 2020
Curesponse featured in the Marker (in Hebrew)
- Jun 3, 2020
Curesponse raises USD $ 6 million (in Hebrew)
Want to know more?